Saol Therapeutics is a privately-held biotech pharmaceutical company with operations in Roswell, GA, Dublin, Ireland, and Hamilton, Bermuda. They are currently conducting two Phase 2 trials and one Phase 3 trial in the United States. Their main focus is on developing therapies for central nervous system disorders such as pain management and spasticity, as well as rare diseases. Saol Therapeutics is committed to providing and advancing therapeutic options for patients and physicians in these underserved populations. For more information, visit www.saolrx.com.